Literature DB >> 31132969

Stroke progression and clinical outcome in ischemic stroke patients with a history of migraine.

Inge A Mulder1, Ghislaine Holswilder2, Marianne Aa van Walderveen2, Irene C van der Schaaf3, Edwin Bennink3, Alexander D Horsch3, L Jaap Kappelle4, Birgitta K Velthuis3, Jan Willem Dankbaar3, Gisela M Terwindt1, Wouter J Schonewille5, Marieke C Visser6, Michel D Ferrari1, Ale Algra3,4,7,8, Marieke Jh Wermer1.   

Abstract

BACKGROUND: Patients with migraine might be more susceptible of spreading depolarizations, which are known to affect vascular and neuronal function and penumbra recovery after stroke. We investigated whether these patients have more severe stroke progression and less favorable outcomes after recanalization therapy.
METHODS: We included patients from a prospective multicenter ischemic stroke cohort. Lifetime migraine history was based on the International Classification of Headache Disorders II criteria. Patients without confirmed migraine diagnosis were excluded. Patients underwent CT angiography and CT perfusion <9 h of onset and follow-up CT after three days. On admission, presence of a perfusion deficit, infarct core and penumbra volume, and blood brain barrier permeability (BBBP) were assessed. At follow-up we assessed malignant edema, hemorrhagic transformation, and final infarct volume. Outcome at three months was evaluated with the modified Rankin Scale (mRS). We calculated adjusted relative risks (aRR) or difference of means (aB) with regression analyses.
RESULTS: We included 600 patients of whom 43 had migraine. There were no differences between patients with or without migraine in presence of a perfusion deficit on admission (aRR: 0.98, 95%CI: 0.77-1.25), infarct core volume (aB: -10.8, 95%CI: -27.04-5.51), penumbra volume (aB: -11.6, 95%CI: -26.52-3.38), mean blood brain barrier permeability (aB: 0.08, 95%CI: -3.11-2.96), malignant edema (0% vs. 5%), hemorrhagic transformation (aRR: 0.26, 95%CI: 0.04-1.73), final infarct volume (aB: -14.8, 95%CI: 29.9-0.2) or outcome after recanalization therapy (mRS > 2, aRR: 0.50, 95%CI: 0.21-1.22).
CONCLUSION: Elderly patients with a history of migraine do not seem to have more severe stroke progression and have similar treatment outcomes compared with patients without migraine.

Entities:  

Keywords:  CT angiography; CT angiography and perfusion; Cerebrovascular disease/stroke; ischemic stroke; migraine; non-contrast CT

Mesh:

Year:  2019        PMID: 31132969     DOI: 10.1177/1747493019851288

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  1 in total

1.  MicroRNA-155 influences cell damage in ischemic stroke via TLR4/MYD88 signaling pathway.

Authors:  Wei Chen; Lingtong Wang; Zhaoping Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.